Type of revascularization and outcome in patients with ischaemic cardiomyopathy and multivessel coronary disease-Reference-Cited by-同舟云学术

Type of revascularization and outcome in patients with ischaemic cardiomyopathy and multivessel coronary disease

Published:2017 Issue:4 Volume:36 Page:238-244
ISSN:1821-4835
Container-title:Srce i krvni sudovi
language:en
Short-container-title:Srce i krvni sudovi

Author:

Popov Tanja,Srdanović Ilija,Bjelić Snežana,Šušak Stamenko,Vulin Aleksandra,Stefanović Maja,Tadić Snežana

Publisher

Centre for Evaluation in Education and Science (CEON/CEES)

Link

https://scindeks-clanci.ceon.rs/data/pdf/1821-4835/2017/1821-48351704238P.pdf

Reference26 articles.

1. The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Guidelines on myocardial revascularization. Eur Heart J (2010);31:2501-55.;

2. Daemen J, Boersma E, Flather M, Booth J, Stables R, Rodriguez A, et al. Long-term safety and efficacy of percutaneous coronary intervention with stenting and coronary artery bypass surgery for multi-vessel coronary artery disease: a meta analysis with 5-year patient-level data from the ARTS, ERACI-II, MASS-II, and SoS trials. Circulation 2008;118:1146-54.;

3. Booth J, Clayton T, Pepper J, et al. Randomized, controlled trial of coronary artery bypass surgery versus percutaneous coronary intervention in patients with multi-vessel coronary artery disease: six year follow-up from the Stent or Surgery Trial (SoS). Circulation 2008;118:381-8.;

4. BARI investigators. Seven-year outcome in the Bypass Angioplasty Revascularization Investigation (BARI) by treatment and diabetic status. J Am Coll Cardiol 2000;35:1122-9.;

5. Kappetein AP, Dawkins KD, Mohr FW, et al. Current percutaneous coronary intervention and coronary artery bypass grafting practices for three-vessel and left main coronary artery disease: insights from the SYNTAX run-in phase. Eur J Cardiothorac Surg 2006;29:486-91.;